Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results

About this update from Electromed, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/eca34850385a6be80535e1895b7c8fba"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3MmBQbEd8lrnjEu1gwTBaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/eca34850385a6be80535e1895b7c8fba","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/jJp6Qwa7_GlP.l3.VDO4Mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/eca34850385a6be80535e1895b7c8fba","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth","length":153,"tagName":"p","attribs":{}},{"type":"text","content":"NEW PRAGUE, Minn., August 26, 2025--(BUSINESS WIRE)--Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2025") and full year ended June 30, 2025 ("FY 2025").","length":308,"tagName":"p"},{"type":"text","content":"Q4 FY 2025 Company Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenue increased 17.3% to a record $17.4 million in Q4 FY 2025, from $14.8 million in the fourth quarter of the prior fiscal year.","length":135,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating income was a record $3.0 million, a 30.2% increase from the fourth quarter of the prior fiscal year.","length":110,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net income was $2.2 million, or $0.25 per diluted share, compared to $1.8 million, or $0.20 per diluted share in the fourth quarter of the prior fiscal year.","length":157,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Electromed was added to the Russell 2000® and 3000® indexes in June 2025.","length":73,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":475,"olType":false},{"type":"text","content":"FY 2025 Company Highlights","length":26,"tagName":"p"},{"type":"list","items"...

More updates from Electromed, Inc.